Karnataka Pauses Hospital Medicine Price Disclosure Rule

The Karnataka government has decided to temporarily halt its controversial mandate on medicine price disclosure for private healthcare providers. The state made this formal commitment before the Karnataka High Court on Friday. Consequently, hospitals will not face punitive action if they do not print landing costs on patient bills starting November 1. This decision offers immediate breathing room to clinicians and medical administrators across the state.
Legal Challenges to the Medicine Price Disclosure Circular
The dispute began after the Food Safety and Drug Administration issued an order on October 1. Specifically, the directive instructed hospitals to display the base purchase price, maximum retail price, and patient charge on every bill. Furthermore, healthcare facilities had to display these figures publicly at billing counters.
However, clinical groups moved swiftly to challenge the government directive in court. The Private Hospitals and Nursing Homes Association filed a joint writ petition alongside private healthcare institutions. The petitioners argued that drug control officials exceeded their statutory authority. In addition, they emphasized that revealing wholesale purchase rates violates confidential commercial contracts. Different hospitals negotiate diverse credit terms and volume discounts with bulk distributors. Therefore, displaying wholesale landing rates could create unwarranted confusion and disrupt normal supply chains.
High Court Proceedings and Government Review
Justice CM Poonacha heard the petition and recorded the official undertaking from the state. Additional Advocate General BV Bhanuprakash explained that authorities are reviewing the policy framework. Meanwhile, the state requested additional time to evaluate the operational concerns of private medical providers. The state counsel urged the bench to avoid an interim stay order. In response, the court secured a clear guarantee that enforcement will remain paused until November 12.
Notably, state health leaders originally championed this policy to curb inflated private healthcare bills. Health authorities wanted patients to see the exact gap between wholesale purchase rates and retail charges. Nevertheless, healthcare administrators maintain that hospital markups cover essential operational overheads. These overheads include biomedical cold-chain storage, pharmacy staff salaries, and emergency supply buffers. The judicial outcome on November 12 will likely shape medical billing standards across India.
Frequently Asked Questions
Q1: Why did Karnataka pause the medicine price disclosure circular?
The state government paused the circular because private healthcare associations challenged its legality in the High Court. Officials sought time to review operational and contractual concerns before enforcement.
Q2: What did the original October 1 circular require hospitals to disclose?
The circular directed hospitals to disclose the procurement landing cost, the maximum retail price, and the final patient price on itemised pharmacy bills.
Q3: When will the Karnataka High Court hear the case next?
The High Court scheduled the next hearing for November 12 to review the government response and determine whether interim orders are required.
References
- Karnataka govt pauses circular on medicine price disclosure by hospitals - ETHealthworld
- Plea in Karnataka HC against direction to hospitals to disclose procurement price of medicines on bills - Bar and Bench
- Will not enforce circular on hospital medicine price disclosure for now: Karnataka government to HC - The Hindu





